⌕
DENTSPLY Sirona · XRAY · Nasdaq
Tenet 38 · Weak
Compare
$8.95−2.35%At closeTenet 38 · Weak
$8.95−0.22 (−2.35%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

DENTSPLY Sirona (XRAY) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● The Motley FoolNov 16, 2026 · 17:45 ET
Dentsply Sirona: 3 Key Takeaways for Long-Term Investors

Management reduced full-year 2026 sales guidance to approximately $3.5 billion. Wellspect Healthcare revenue grew 10% year over year to $92 million.…

● Zacks Investment ResearchNov 13, 2026 · 04:41 ET
New Strong Sell Stocks for November 13th

XRAY, BROS and GECC have been added to the Zacks Rank #5 (Strong Sell) List on November 13, 2026.…

● Seeking AlphaNov 7, 2026 · 11:14 ET
DENTSPLY SIRONA Inc. (XRAY) Q3 2026 Earnings Call Transcript

DENTSPLY SIRONA Inc. ( XRAY ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Suzanne Hatcher Daniel Scavilla - President, CEO, Interim Principal Financial Officer & Director John Fortson - Execut…

● MarketBeatNov 6, 2026 · 18:17 ET
DENTSPLY SIRONA Q3 Earnings Call Highlights

DENTSPLY SIRONA NASDAQ: XRAY lowered its full-year earnings outlook after third-quarter sales fell across its dental businesses, as pressure from European distributor inventory reductions, the Middle East conflict and hi…

● Zacks Investment ResearchNov 6, 2026 · 10:06 ET
XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook Cut

DENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.…

● Zacks Investment ResearchNov 5, 2026 · 20:00 ET
Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street e…

● Zacks Investment ResearchNov 5, 2026 · 18:46 ET
Dentsply International (XRAY) Q3 Earnings and Revenues Miss Estimates

Dentsply International (XRAY) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.37 per share a year ago.…

● GlobeNewsWireNov 5, 2026 · 16:01 ETCOMPANY'S OWN WORDS
Dentsply Sirona Reports Third Quarter 2026 Results

News Summary Q3 2026 net sales of $836 million Q3 2026 GAAP gross margin of 52.9% , GAAP diluted loss per share of ($0.01) Q3 2026 adjusted gross margin of 54.5% , adjusted EBITDA margin of 17.3% , adjusted EPS of $0.29 …

● Zacks Investment ResearchNov 4, 2026 · 10:46 ET
DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?

DENTSPLY SIRONA faces Q3 earnings pressure from weak dental demand, tariff costs and segment challenges, while Wellspect's growth may offer some relief.…

● PRNewsWireOct 27, 2026 · 15:28 ET
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

● GlobeNewsWireOct 20, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5

CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thurs…

● Zacks Investment ResearchOct 12, 2026 · 13:25 ET
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal

XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.…

● Defense WorldOct 12, 2026 · 02:02 ET
Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendments

What happened Dentsply Sirona Inc. (NASDAQ: XRAY) said on October 8, 2026, that lenders consented to amendments to its revolving credit facility and related note agreements. The company entered the Third Amendment to Cre…

● GlobeNewsWireOct 6, 2026 · 09:07 ETCOMPANY'S OWN WORDS
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement

The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and technology. The expanded …

● Defense WorldSep 18, 2026 · 04:10 ET
DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell?

Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The stock had previously clos…

● Defense WorldSep 18, 2026 · 03:13 ET
Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY

Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 451.5% in a recent quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi…

● Zacks Investment ResearchSep 17, 2026 · 12:26 ET
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now

XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.…

● Zacks Investment ResearchSep 8, 2026 · 13:15 ET
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure

XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.…

● PRNewsWireSep 7, 2026 · 15:32 ET
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

● GlobeNewsWireSep 3, 2026 · 16:15 ETCOMPANY'S OWN WORDS
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference

CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global Healthcare Conferenc…

● Schwab NetworkSep 2, 2026 · 09:00 ET
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities

"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the "seasonality effect," a crowde…

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Quiet tape today.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.